HIV

​Last year, a proof-of-concept study described how the CRISPR-Cas9 gene-editing tool could be used to eliminate HIV from infected cells. In a potential step towards a permanent cure, the team has shown that the technique keeps the virus from spreading, and in latent cases, rips it from its hideout.

The HIV virus has completely vanished from the bloodstream of a 44-year-old man participating in a medical trial. Although more time is needed to confirm whether the result is from the new approach or from anti-HIV drugs that the patient was taking, the implications of the research are encouraging.

A team from the Lewis Katz School of Medicine at Temple University has successfully tested a gene editing system, demonstrating its ability to eliminate the HIV-1 virus from DNA in human cells grown in culture.

A 17-year-old Canadian has earned first place for engineering a system that improves air quality in airplane cabins at Intel's 2015 International Science and Engineering Fair, which the company claims is the biggest high school science competition in the world.

A vaccine for the AIDS virus may become possible through a new compound proving highly effective in preventing HIV infection. The scientists say with its ability to block multiple strains of infection, the technique has huge potential to provide long-lasting protection against the deadly virus.

Researchers have developed a material that could offer women a new means of protection against HIV. Demonstrated in the form of a tampon, the material is capable of carrying substantial loads of medicine, dissolving and releasing the drugs once its comes into contact with moisture.

Medicine Patent Pool and pharmaceutical company Gilead have agreed to produce a generic version of a new HIV treatment drug to made available in 112 developing and middle income countries.

Researchers from Temple University School of Medicine have discovered how to permanently extricate HIV-1 from human cells, possibly avoiding the need for lifelong drug treatment. Though in its very early stages, this may prove to be a critical step in permanently defeating the disease.

A new vaccine candidate developed at the Oregon Health and Science University has been shown to wipe out the HIV equivalent in monkeys. The breakthrough could lead to a human vaccine preventing the onset of HIV/AIDS and even cure patients currently on anti-retroviral drugs.

Researchers at the Stanford School of Medicine have engineered immune cells to resist HIV infection in an approach that could be used to replace drug treatments for HIV patients.

Scientists have discovered that a combination of potent antibodies could neutralize HIV and lead to new therapies.